AstraZeneca boss says vaccine effective against variants – Sydney Morning Herald

The AstraZeneca vaccine will offer strong protection against both the Brazilian and South African coronavirus variants, according to the companys global chief who says mixing the first and second vaccine doses from different companies may provide a better approach.
AstraZeneca chief executive Pascal Soriot said new data weakened the result of a South African study which found the vaccine had only 10 per cent efficacy against the local variant. It underrepresented old people, for whom the vaccine…

Click here to view the original article.